Drugs Made In America Acquisition II Unit Insider Trades
NASDAQ: DMIIUFinancial ServicesShell CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Drugs Made In America Acquisition II Unit insider activity
No Drugs Made In America Acquisition II Unit insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Do Catherine (Director) reporting a transaction in 100,000 shares on Sep 26, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DMIIU's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
DMIIU insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | Sale | 7,966,667 | — | Form 4 |
| Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | other | 400,000 | — | Form 4 |
| Sep 26, 2025 | Stockwell LynnCEO and Exe. Chair of Board | Buy | 700,000 | — | Form 4 |
| Sep 26, 2025 | Worman Glenn C.CFO | other | 100,000 | — | Form 4 |
| Sep 26, 2025 | Prasad Sridhar G.Director | other | 100,000 | — | Form 4 |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC10% Owner | Sale | 7,966,667 | — | Form 4 |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC10% Owner | other | 400,000 | — | Form 4 |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC10% Owner | Buy | 700,000 | — | Form 4 |
| Sep 26, 2025 | Shulgan Myron W.Director | other | 100,000 | — | Form 4 |
| Sep 26, 2025 | Do CatherineDirector | other | 100,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4